Results 131 to 140 of about 8,552 (153)

Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients

Bone, 2008
Seiji Fukumoto, Masanori Minagawa, Mika Yamauchi   +2 more
exaly   +2 more sources

Fibroblast growth factor 23 (FGF23) and hypophosphatemia in patients with COPD

European Respiratory Journal, 2011
Introduction: Previous studies highlighted the importance of phosphate depletion in COPD patients and the association between correction of hypophosphatemia and improvement in respiratory muscle function. Fibroblast Growth Factor 23 (FGF23) is a recently discovered circulating protein that plays a crucial role ...
Mohamed Elsammak, Adel Attia, Moosa Suleman   +2 more
openaire   +1 more source

The couple fibroblast growth factor 23 (FGF23)/Klotho

Annales de biologie clinique, 2015
The fibrobalst growth factor 23 (FGF23) is a protein secreted in the plasma by bone cells. FGF23 controls phosphate and calcitriol plasma concentration. Its main physiological targets are the kidney and the parathyroid gland. Its production is stimulated by phosphate intake and plasma calcitriol levels.
openaire   +2 more sources

The participation of fibroblast growth factor 23 (FGF23) in the progression of osteoporosis via JAK/STAT pathway

Journal of Cellular Biochemistry, 2018
AbstractOsteoporosis (OP) is a major skeletal disorder for the old man. The fibroblast growth factor 23 (FGF23) is a phosphaturic hormone produced by osteoblasts and osteocytes. However, the regulatory mechanisms of FGF23 in the progression of osteoporosis remain poorly understood.
Lijun Xu, Huijuan Zhang, Yurong Wang
exaly   +3 more sources

Assessment of Fibroblast Growth Factor-23 ( Fgf23) as Risk Factor for Diastolic Dysfunction in Hemodialysis Patients

Journal of Nephrology & Renal Diseases, 2017
Background: Cardiovascular disease is the most common cause of death in patients with chronic kidney disease. Diastolic dysfunction is an important risk factor result in development of advanced cardiovascular disease. Fibroblast growth factor- 23 (FGF23) secretes in response to hypophosphatemia as a result of renal excretion of phosphate.
Malihe Mohammad Hosseini, Narges Sadat Zahed, Muhanna Kazempour, Roxana sadeghi, Seyed Morvarid Dadras, Samira Tabiban   +5 more
openaire   +1 more source

Regulation of fibroblast growth factor 23 (FGF23) in metabolic derangement

Increased incidence of metabolic syndrome is attributable to Western dietary patterns. Metabolic syndrome enhances risk of developing diabetes mellitus type 2 or cardiovascular diseases, which are associated with lactic acidosis, diabetic ketoacidosis and hyperhomocysteinemia. Increased lactate, ketone body or homocysteine levels are therefore relevant
openaire   +1 more source

Serum and vascular fibroblast growth factor 23 (FGF23) are associated with vascular calcification

Atherosclerosis, 2021
J.J. Donate-Correa, E. Martín-Núñez, C. Hernández-Carballo, C.M. Ferri, M. Arévalo-Gómez, A. González-Luis, S. Rodríguez-Ramos, P. Cerro-López, Á. López-Castillo, A. Delgado-Molinos, C. Mora-Fernández, J.F. Navarro-González   +11 more
openaire   +1 more source

241 Fibroblast growth factor 23 (FGF23) promotes prostate cancer growth

European Journal of Cancer, 2015
A. Chow, S. Trebinjac, U. Emmenegger
openaire   +1 more source

FIBROBLAST GROWTH FACTOR-23 (FGF23) IS A NOVEL BIOLOGICAL MARKER IN HEART FAILURE

2022
Alieva, A. M., Pinchuk, T. V., Kislyakov, V. A., Valiev, R. K., Arakelyan, R. A., Nikitin, I. G.   +5 more
openaire   +1 more source

Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets

Journal of Bone and Mineral Research, 2013
Olivier Bonny, Francesco Hofmann, Noemie Beluch   +2 more
exaly